Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Allyson Parry

Showing results (1-10 of 30) with videos related to

Pageof 3
Sort By:
The British Journal of General Practice : the Journal of the Royal College of General Practitioners|August 29, 2020
Attention deficit hyperactivity disorder in adults: common in primary care, misdiagnosed, and impairing, but highly responsive to treatmentSally Cubbin, Laurence Leaver, Allyson Parry
The British Journal of General Practice : the Journal of the Royal College of General Practitioners|November 30, 2023
Supporting adults with autism - don't forget comorbid ADHDLaurence Leaver, Sally Cubbin, Allyson Parry
Clinical Medicine (London, England)|January 25, 2023
Fibromyalgia and attention deficit hyperactivity disorderLaurence Leaver, Allyson Parry, Helen Read
Practical Neurology|September 19, 2009
Thunderclap headacheNiraj Mistry, Liberty Mathew, Allyson Parry
Clinical Medicine (London, England)|September 29, 2023
ADHD in obesity clinics: common, often missed, highly treatableLaurence Leaver, Allyson Parry, Sally Cubbin
Current Opinion in Oncology|August 20, 2019
Neurofibromatosis type 2 and related disordersDorothy Halliday, Allyson Parry, D Gareth Evans
Disability and Rehabilitation|March 21, 2018
First report of the efficacy of vestibular rehabilitation in improving function in patients with Neurofibromatosis type 2: an observational cohort study in a clinical settingBeatrice Emmanouil, Katherine Browne, Dorothy Halliday, et al.
The British Journal of Radiology|July 26, 2016
Comparing the sensitivity of linear and volumetric MRI measurements to detect changes in the size of vestibular schwannomas in patients with neurofibromatosis type 2 on bevacizumab treatmentKatrina A Morris, Allyson Parry, Pieter M Pretorius
JAMA Neurology|November 10, 2015
Novel Variant of Miller Fisher Syndrome Occurring With Tumor Necrosis Factor α Antagonist TherapyGokulan Ratnarajan, Alexander Thompson, Caroline Dodridge, et al.
Ophthalmic Research|October 21, 2021
Structural Abnormalities of the Central Retina in Neurofibromatosis Type 2Beatrice Emmanouil, Martin Wasik, Peter Charbel Issa, et al.
Pageof 3

Showing results (1-10 of 30) with videos related to

Sort By:
Pageof 3
The British Journal of General Practice : the Journal of the Royal College of General Practitioners|August 29, 2020
Attention deficit hyperactivity disorder in adults: common in primary care, misdiagnosed, and impairing, but highly responsive to treatmentSally Cubbin, Laurence Leaver, Allyson Parry
The British Journal of General Practice : the Journal of the Royal College of General Practitioners|November 30, 2023
Supporting adults with autism - don't forget comorbid ADHDLaurence Leaver, Sally Cubbin, Allyson Parry
Clinical Medicine (London, England)|January 25, 2023
Fibromyalgia and attention deficit hyperactivity disorderLaurence Leaver, Allyson Parry, Helen Read
Practical Neurology|September 19, 2009
Thunderclap headacheNiraj Mistry, Liberty Mathew, Allyson Parry
Clinical Medicine (London, England)|September 29, 2023
ADHD in obesity clinics: common, often missed, highly treatableLaurence Leaver, Allyson Parry, Sally Cubbin
Current Opinion in Oncology|August 20, 2019
Neurofibromatosis type 2 and related disordersDorothy Halliday, Allyson Parry, D Gareth Evans
Disability and Rehabilitation|March 21, 2018
First report of the efficacy of vestibular rehabilitation in improving function in patients with Neurofibromatosis type 2: an observational cohort study in a clinical settingBeatrice Emmanouil, Katherine Browne, Dorothy Halliday, et al.
The British Journal of Radiology|July 26, 2016
Comparing the sensitivity of linear and volumetric MRI measurements to detect changes in the size of vestibular schwannomas in patients with neurofibromatosis type 2 on bevacizumab treatmentKatrina A Morris, Allyson Parry, Pieter M Pretorius
JAMA Neurology|November 10, 2015
Novel Variant of Miller Fisher Syndrome Occurring With Tumor Necrosis Factor α Antagonist TherapyGokulan Ratnarajan, Alexander Thompson, Caroline Dodridge, et al.
Ophthalmic Research|October 21, 2021
Structural Abnormalities of the Central Retina in Neurofibromatosis Type 2Beatrice Emmanouil, Martin Wasik, Peter Charbel Issa, et al.
Pageof 3